What triggers sapropterin's regulation of phenylalanine?

Sapropterin is a synthetic form of tetrahydrobiopterin (BH4), the essential cofactor for the enzyme phenylalanine hydroxylase (PAH). It doesn’t regulate phenylalanine directly; it enables PAH to hydroxylate phenylalanine to tyrosine.

What triggers the effect:
- Availability of PAH activity that can be boosted by BH4 (i.e., BH4-responsive PKU patients).
- Presence of phenylalanine as the substrate: when Phe is high and BH4 (from sapropterin) is available, PAH more effectively converts Phe to Tyr.
- The BH4 cycle requires regeneration (BH4 → BH2 → back to BH4) so the reaction can continue.

In clinical practice, responsiveness is checked with a BH4 loading test: if blood phenylalanine levels fall after starting sapropterin, the patient is BH4-responsive and treatment lowers Phe. Non-responders don’t show a significant Phe decrease.